Cargando…
Clinical Outcomes of Acute Myeloid Leukemia Patients Harboring the RUNX1 Mutation: Is It Still an Unfavorable Prognosis? A Cohort Study and Meta-Analysis
SIMPLE SUMMARY: Acute myeloid leukemia (AML) with mutated RUNX1 (RUNX1(mut)) has an adverse prognosis based on the 2022 European LeukemiaNet risk stratification. However, the WHO classifications of 2022 removed RUNX1 mutations from the unique entity because of various prognoses and treatment outcome...
Autores principales: | Rungjirajittranon, Tarinee, Siriwannangkul, Theerapat, Kungwankiattichai, Smith, Leelakanok, Nattawut, Rotchanapanya, Wannaphorn, Vittayawacharin, Pongthep, Mekrakseree, Benjamaporn, Kulchutisin, Kamolchanok, Owattanapanich, Weerapat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659296/ https://www.ncbi.nlm.nih.gov/pubmed/36358658 http://dx.doi.org/10.3390/cancers14215239 |
Ejemplares similares
-
Thrombotic and Hemorrhagic Incidences in Patients After Discharge from COVID-19 Infection: A Systematic Review and Meta-Analysis
por: Rungjirajittranon, Tarinee, et al.
Publicado: (2021) -
Simplified predictive scores for thrombosis and bleeding complications in newly diagnosed acute leukemia patients
por: Owattanapanich, Weerapat, et al.
Publicado: (2023) -
A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: a case report
por: Rungjirajittranon, Tarinee, et al.
Publicado: (2019) -
Comparison of the Long-Term Remission of Rituximab and Conventional Treatment
for Acquired Thrombotic Thrombocytopenic Purpura: A Systematic Review and
Meta-Analysis
por: Owattanapanich, Weerapat, et al.
Publicado: (2019) -
Clinical Outcomes Based on Measurable Residual Disease Status in Patients with Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
por: Rotchanapanya, Wannaphorn, et al.
Publicado: (2020)